OESOPHAGEAL DYSPLASIA

OESOPHAGEAL DYSPLASIA was reported 52 times

OESOPHAGEAL DYSPLASIA is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Interleukin-5 Antagonist [EPC] 3 0.0044
1 Interferon alfa-2b [EPC] 1 0.0005
2 Guanylate Cyclase-C Agonist [EPC] 1 0.0005
3 Sigma-1 Agonist [EPC] 1 0.0001
4 Soluble Guanylate Cyclase Stimulator [EPC] 2 0.0001
5 Aluminum Complex [EPC] 1 0.0000
6 Provitamin D2 Compound [EPC] 1 0.0000
7 Parathyroid Hormone-Related Peptide Analog [EPC] 1 0.0000
8 P2Y12 Platelet Inhibitor [EPC] 3 0.0000
9 Nitrate Vasodilator [EPC] 2 0.0000
10 Histamine-2 Receptor Antagonist [EPC] 2 0.0000
11 Prostacycline Vasodilator [EPC] 2 0.0000
12 Topoisomerase Inhibitor [EPC] 1 0.0000
13 Janus Kinase Inhibitor [EPC] 2 0.0000
14 Phosphodiesterase 4 Inhibitor [EPC] 2 0.0000
15 gamma-Aminobutyric Acid-ergic Agonist [EPC] 1 0.0000
16 Dietary Cholesterol Absorption Inhibitor [EPC] 1 0.0000
17 Prostaglandin Analog [EPC] 1 0.0000
18 HMG-CoA Reductase Inhibitor [EPC] 4 0.0000
19 5-alpha Reductase Inhibitor [EPC] 1 0.0000
20 Platelet Aggregation Inhibitor [EPC] 5 0.0000
21 Sulfonylurea [EPC] 1 0.0000
22 Phosphodiesterase 5 Inhibitor [EPC] 1 0.0000
23 Angiotensin Converting Enzyme Inhibitor [EPC] 1 0.0000
24 Interleukin-6 Receptor Antagonist [EPC] 1 0.0000
25 Proton Pump Inhibitor [EPC] 4 0.0000
26 Benzodiazepine [EPC] 4 0.0000
27 Expectorant [EPC] 1 0.0000
28 Nonsteroidal Anti-inflammatory Drug [EPC] 6 0.0000
29 Retinoid [EPC] 1 0.0000
30 Platinum-based Drug [EPC] 1 0.0000
31 Factor Xa Inhibitor [EPC] 1 0.0000
32 beta-Adrenergic Blocker [EPC] 1 0.0000
33 Angiotensin 2 Receptor Blocker [EPC] 1 0.0000
34 Corticosteroid [EPC] 4 0.0000
35 Vitamin B12 [EPC] 1 0.0000
36 Tumor Necrosis Factor Blocker [EPC] 3 0.0000
37 Vitamin C [EPC] 1 0.0000
38 GLP-1 Receptor Agonist [EPC] 1 0.0000
39 Loop Diuretic [EPC] 1 0.0000
40 Thalidomide Analog [EPC] 1 0.0000